Aristotle Atlantic Partners’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.5M | Sell |
2,879,317
-61,895
| -2% | -$721K | 1.02% | 29 |
|
|
2025
Q1 | $21.9M | Buy |
2,941,212
+54,510
| +2% | +$405K | 0.74% | 41 |
|
|
2024
Q4 | $17.3M | Sell |
2,886,702
-114,499
| -4% | -$686K | 0.54% | 51 |
|
|
2024
Q3 | $15.4M | Buy |
3,001,201
+27,013
| +0.9% | +$138K | 0.48% | 51 |
|
|
2024
Q2 | $10.8M | Sell |
2,974,188
-18,375
| -0.6% | -$66.5K | 0.35% | 61 |
|
|
2024
Q1 | $9.61M | Sell |
2,992,563
-58,121
| -2% | -$187K | 0.31% | 64 |
|
|
2023
Q4 | $14.9M | Sell |
3,050,684
-7,522
| -0.2% | -$36.9K | 0.53% | 54 |
|
|
2023
Q3 | $16.7M | Sell |
3,058,206
-46,755
| -2% | -$255K | 0.67% | 51 |
|
|
2023
Q2 | $20.8M | Buy |
3,104,961
+1,197,872
| +63% | +$8.04M | 0.78% | 44 |
|
|
2023
Q1 | $16.8M | Buy |
1,907,089
+26,522
| +1% | +$234K | 0.87% | 42 |
|
|
2022
Q4 | $14.4M | Sell |
1,880,567
-13,828
| -0.7% | -$106K | 0.8% | 44 |
|
|
2022
Q3 | $13.5M | Buy |
1,894,395
+565,127
| +43% | +$4.02M | 0.82% | 42 |
|
|
2022
Q2 | $10.8M | Buy |
1,329,268
+569,856
| +75% | +$4.61M | 0.83% | 35 |
|
|
2022
Q1 | $10.5M | Buy |
759,412
+13,617
| +2% | +$189K | 0.65% | 38 |
|
|
2021
Q4 | $20.9M | Buy |
745,795
+18,461
| +3% | +$518K | 1.21% | 28 |
|
|
2021
Q3 | $24.7M | Buy |
727,334
+9,684
| +1% | +$329K | 1.64% | 22 |
|
|
2021
Q2 | $29.3M | Buy |
717,650
+146,708
| +26% | +$5.99M | 1.93% | 18 |
|
|
2021
Q1 | $23M | Buy |
570,942
+22,562
| +4% | +$908K | 1.68% | 23 |
|
|
2020
Q4 | $32.4M | Buy |
548,380
+17,235
| +3% | +$1.02M | 2.5% | 10 |
|
|
2020
Q3 | $25.8M | Buy |
531,145
+19,413
| +4% | +$944K | 2.28% | 15 |
|
|
2020
Q2 | $24.8M | Buy |
511,732
+140,891
| +38% | +$6.82M | 2.38% | 12 |
|
|
2020
Q1 | $10.3M | Buy |
370,841
+7,232
| +2% | +$201K | 1.57% | 26 |
|
|
2019
Q4 | $10.9M | Buy |
363,609
+313,150
| +621% | +$9.37M | 1.39% | 28 |
|
|
2019
Q3 | $1.56M | Buy |
+50,459
| New | +$1.56M | 0.45% | 46 |
|